(PVAL) Putnam Focused Large Cap - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US7467293004 • Large Value
PVAL: Stocks, Large-Cap, Value, US, Companies
Putnam Focused Large Cap Value ETF (PVAL) is a targeted investment vehicle designed for those seeking exposure to U.S. large-cap equities with a value orientation. The fund primarily allocates its capital to common stocks of domestic companies, emphasizing value stocks that present opportunities for capital appreciation, dividend income, or a combination of both.
Under normal market conditions, PVAL commits at least 80% of its net assets to large-cap companies. For reference, these firms typically resemble those included in the Russell 1000 Value Index, a widely recognized benchmark for large-cap value stocks. While the funds primary focus is on large-cap equities, it retains the flexibility to invest in mid-sized companies, allowing the portfolio managers to capitalize on undervalued opportunities across different market caps.
As an actively managed ETF, PVAL leverages Putnams expertise in value investing to identify companies with strong fundamentals that are trading at a discount to their intrinsic value. The funds investment strategy is grounded in rigorous research and a disciplined approach to stock selection, aiming to deliver long-term returns that outperform the broader market.
With approximately $2.1 billion in assets under management, PVAL offers investors a cost-effective way to gain exposure to a concentrated portfolio of value-oriented large-cap stocks. The funds structure allows for transparency and liquidity, making it accessible to both institutional and retail investors seeking to incorporate a value equity allocation into their portfolios.
For investors and fund managers evaluating PVAL, its important to consider its role within a broader investment strategy. The funds focus on value stocks can provide a diversification benefit for portfolios overweight in growth-oriented investments. Additionally, its large-cap bias aligns with the stability and liquidity typically associated with larger, established companies, while its value orientation seeks to capture upside potential in undervalued sectors or industries.
Additional Sources for PVAL ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PVAL ETF Overview
Market Cap in USD | 2,165m |
Category | Large Value |
TER | 0.56% |
IPO / Inception | 2021-05-25 |
PVAL ETF Ratings
Growth 5y | 69.9% |
Fundamental | - |
Dividend | 52.4% |
Rel. Strength Industry | -0.08 |
Analysts | - |
Fair Price Momentum | 36.31 USD |
Fair Price DCF | - |
PVAL Dividends
Dividend Yield 12m | 1.03% |
Yield on Cost 5y | 1.60% |
Annual Growth 5y | 39.37% |
Payout Consistency | 100.0% |
PVAL Growth Ratios
Growth Correlation 3m | 29.5% |
Growth Correlation 12m | 89.5% |
Growth Correlation 5y | 91.3% |
CAGR 5y | 12.57% |
CAGR/Max DD 5y | 0.76 |
Sharpe Ratio 12m | 0.75 |
Alpha | 0.28 |
Beta | 0.83 |
Volatility | 17.26% |
Current Volume | 1002k |
Average Volume 20d | 619.7k |
As of March 09, 2025, the stock is trading at USD 37.90 with a total of 1,002,003 shares traded.
Over the past week, the price has changed by -2.82%, over one month by -2.94%, over three months by -2.85% and over the past year by +12.00%.
Yes. Based on ValueRay Analyses, Putnam Focused Large Cap (NYSE ARCA:PVAL) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 69.94 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PVAL as of March 2025 is 36.31. This means that PVAL is currently overvalued and has a potential downside of -4.2%.
Putnam Focused Large Cap has no consensus analysts rating.
According to ValueRays Forecast Model, PVAL Putnam Focused Large Cap will be worth about 41.7 in March 2026. The stock is currently trading at 37.90. This means that the stock has a potential upside of +10.08%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 41.7 | 10.1% |